Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Mallinckrodt
Citi
UBS
Baxter
Moodys
Farmers Insurance
Julphar
Johnson and Johnson

Generated: June 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 091528

« Back to Dashboard

NDA 091528 describes HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE, which is a drug marketed by Actavis Elizabeth, Avanthi Inc, and Novel Labs Inc, and is included in three NDAs. It is available from four suppliers. Additional details are available on the HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE profile page.

The generic ingredient in HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE is homatropine methylbromide; hydrocodone bitartrate. There are five drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the homatropine methylbromide; hydrocodone bitartrate profile page.
Summary for 091528
Pharmacology for NDA: 091528
Mechanism of ActionOpioid Agonists
Suppliers and Packaging for NDA: 091528
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE homatropine methylbromide; hydrocodone bitartrate TABLET;ORAL 091528 ANDA Novel Laboratories, Inc. 40032-118 N 40032-118-03
HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE homatropine methylbromide; hydrocodone bitartrate TABLET;ORAL 091528 ANDA Novel Laboratories, Inc. 40032-118 N 40032-118-24

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1.5MG;5MG
Approval Date:Apr 20, 2011TE:AARLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Healthtrust
Daiichi Sankyo
Harvard Business School
Deloitte
McKesson
US Army
Chubb
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.